Dihexa

Dihexa is a synthetic angiotensin IV-derived compound investigated in preclinical research involving HGF/c-Met signaling, synaptic biology and neural plasticity.

Dihexa is commonly described as a synthetic peptidomimetic compound derived from angiotensin IV chemistry rather than a conventional therapeutic peptide product.

Its molecular design was developed from angiotensin IV-related research, with modifications studied for distinct stability and signaling properties in experimental models.

HGF is a signaling protein that binds c-Met and participates in context-dependent pathways involving cell growth, survival, motility and differentiation.

c-Met is a receptor tyrosine kinase. HGF binding can activate intracellular signaling networks, including PI3K/AKT and MAPK/ERK, depending on the model and cell type.

Preclinical research has investigated Dihexa as a positive modulator of HGF/c-Met signaling. These findings do not establish a clinical effect in humans.

Synaptogenesis is the formation of new connections between neurons. It is measured through defined structural and functional endpoints in experimental research.

Laboratory and animal models have explored Dihexa in relation to synaptic formation, dendritic structure and adaptive neuronal signaling. The evidence remains primarily preclinical.

Dendritic spines are small neuronal protrusions that receive many excitatory synaptic inputs and are studied as structural markers of synaptic organization and plasticity.

PI3K/AKT is one pathway associated with c-Met activation. Research has examined whether Dihexa-related modulation of HGF/c-Met signaling influences this pathway under controlled preclinical conditions.

No. A cognitive benefit, clinical efficacy and clinical safety have not been established in humans. Available findings are predominantly preclinical.

No. The ELIX LABS research compound is not presented as an approved medicine and must not be used to diagnose, treat, cure or prevent disease.

Store the sealed research material as directed by its batch documentation, protected from light, moisture and inappropriate temperature variation. Laboratories should follow validated handling procedures.

No. For laboratory research use only. Not for human consumption. Human clinical efficacy and safety have not been established.

The product includes access to the four listed research resources and available batch-specific analytical documentation, including the Certificate of Analysis.